(2-Chloro-5-methoxy-phenyl)-hydrazine; hydrochloride, 95.0%, 5g

1,6-Dibromoisoquinolin-3-amine, 95.0%, 1g

9H-xanthene-9-carbohydrazide, 5g

5-Fluoro-1H-indazol-3-amine, 95.0%, 1g

1-(1-Ethyl-3-methyl-1 H -pyrazol-4-yl)-ethylamine, 100mg

Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-2-carboxylate, 95.0%, 250mg

4,6-Bis(3,5-dichlorophenyl)-2-methylpyrimidine>98.0%(HPLC)(N)1g

Tetrakis(trimethylsiloxy)titanium, >95%, 25g

2-Chloro-6-(trifluoromethyl)nicotinaldehyde, 95.0%, 250mg

(R)-2-((tert-Butoxycarbonyl)amino)-3-(pyridin-4-yl)propanoic acid, 95.0%, 250mg

Estreptavidina, mínimo 15 U/mg, liofilizado, 5 mg, envase de plástico.

3-Bromobenzo[b]thiophene-2-carbaldehyde, 95+%, 10g

3-Nitro-1H-pyrrolo[3,2-b]pyridine, 98+%, 250mg